Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20027407HPVENSG00000176697.20protein_codingBDNFNoNo627A0A0E3SU01
P23560
TVIS44040782HTLV-1ENSG00000176697.20protein_codingBDNFNoNo627A0A0E3SU01
P23560
TVIS44040936HTLV-1ENSG00000176697.20protein_codingBDNFNoNo627A0A0E3SU01
P23560
TVIS44040935HTLV-1ENSG00000176697.20protein_codingBDNFNoNo627A0A0E3SU01
P23560
TVIS44046696HTLV-1ENSG00000176697.20protein_codingBDNFNoNo627A0A0E3SU01
P23560
TCGA Plot Options
Drug Information
GeneBDNF
DrugBank IDDB11823
Drug NameEsketamine
Target IDBE0003394
UniProt IDP23560
Regulation Typeagonist
PubMed IDs29736744; 24103211; 22407616
CitationsMolero P, Ramos-Quiroga JA, Martin-Santos R, Calvo-Sanchez E, Gutierrez-Rojas L, Meana JJ: Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review. CNS Drugs. 2018 May;32(5):411-420. doi: 10.1007/s40263-018-0519-3.@@Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A, Iqbal S, Mahoney JJ 3rd, De La Garza R 2nd, Charney DS, Newton TF, Mathew SJ: Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol. 2014 Feb;17(2):331-6. doi: 10.1017/S1461145713001119. Epub 2013 Oct 8.@@Autry AE, Monteggia LM: Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev. 2012 Apr;64(2):238-58. doi: 10.1124/pr.111.005108. Epub 2012 Mar 8.
GroupsApproved; Investigational
Direct ClassificationChlorobenzenes
SMILESCN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl
Pathways
PharmGKB
ChEMBLCHEMBL395091